Literature DB >> 1600045

Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol.

A G Fraser1, M Hudson, A M Sawyerr, S B Rosalki, R E Pounder.   

Abstract

Twenty healthy male subjects were studied twice using a double-blind, randomized placebo controlled, cross-over study design. Alcohol absorption (integrated 2-h plasma alcohol concentration, peak plasma alcohol concentration, and time to reach peak concentration) was measured after 8 daily doses of either placebo or 300 mg ranitidine. They were given alcohol, 0.15 g/kg of body weight by month after an evening meal. Compared with placebo, there was a trend towards higher integrated 2-h plasma alcohol concentrations (3.17 and 3.89 mg. h/dL, respectively, P = 0.07), and a statistically significant increase in mean peak plasma alcohol concentration after dosing with ranitidine (4.92 and 6.47 mg/dL, respectively, P = 0.05).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600045     DOI: 10.1111/j.1365-2036.1992.tb00270.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

Review 1.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

2.  First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal.

Authors:  R Sharma; R T Gentry; R T Lim; C S Lieber
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

3.  Inter-individual and intra-individual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal.

Authors:  A G Fraser; S B Rosalki; G D Gamble; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

4.  H2 antagonists and blood alcohol levels.

Authors:  J H Lewis; R L McIsaac
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

5.  Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime.

Authors:  M J Kendall; F Spannuth; R P Walt; G J Gibson; K A Hale; R Braithwaite; M J Langman
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

6.  Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults.

Authors:  J A McDowell; G E Chittick; C P Stevens; K D Edwards; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 7.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

8.  Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Authors:  A S Brown; J R Fiaterone; C P Day; M K Bennett; P J Kelly; O F James
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.

Authors:  A Mallat; F Roudot-Thoraval; J F Bergmann; H Trout; G Simonneau; C Dutreuil; L E Blanc; D Dhumeaux; J C Delchier
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.